NeuroKaire (formerly Genetika+) Publication Featured in Future Medicine

Find out more about the extraordinary work happening at NeuroKaire (formerly Genetika+) as we bring precision medicine into practice to optimize depression treatment

Neurology
Neuroscience
WriTten By
Future Medicine
Published date
Jul 26, 2022
Find out more about the extraordinary work happening at NeuroKaire (formerly Genetika+) as we bring precision medicine into practice to optimize depression treatment

Genetika+ is developing a precision medicine tool to optimize the treatment of depression by helping physicians find the best drug therapy for their patients. The tool builds on traditional pharmacogenetics, introducing a ‘brain-in-a-dish’ screening platform for each patient that will overcome the challenge of limited pharmacodynamic knowledge of pharmacogenetics (PGx). In addition to PGx, our platform integrates patient data with innovative blood-derived patient neurons to test all categories of antidepressants and predict the best drug for each patient. This offers patients optimal drug treatment, allowing a faster response, fewer side effects and lower dosing.

Previous Article
Next Article

Contact Us

New Jersey Office

78 John Miller Way,
Kearny, NJ 07032, USA

Tel Aviv Office

Yigal Alon Street 126
Tel Aviv-Yafo, Israel

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.